Influenza A Virus H1N1 Neuraminidase (NA) antibody [GT288] detects Influenza A Virus H1N1 Neuraminidase (NA) protein by western blot analysis. A. 30 μg DF1 whole cell lysate/extract (untreated) B. 30 μg whole cell lysate/extract of Influenza A (WSN) infected DF1 cell for 10 hr 10% SDS-PAGE Influenza A Virus H1N1 Neuraminidase (NA) antibody [GT288] (GTX629696) dilution: 1:1000 The HRP-conjugated anti-mouse IgG antibody (GTX213111-01) was used to detect the primary antibody.
![Influenza A viral lysates were separated by 10% SDS-PAGE, and the membrane was blotted with Influenza A virus H1N1 NA (Neuraminidase) antibody [GT288] (GTX629696) diluted at 1:1000. The HRP-conjugated anti-mouse IgG antibody (GTX213111-01) was used to detect the primary antibody.](https://www.genetex.com/upload/website/prouct_img/normal/GTX629696/GTX629696_41421_20230721_WB_H1N1_23072519_760.webp "Influenza A viral lysates were separated by 10% SDS-PAGE, and the membrane was blotted with Influenza A virus H1N1 NA (Neuraminidase) antibody [GT288] (GTX629696) diluted at 1:1000. The HRP-conjugated anti-mouse IgG antibody (GTX213111-01) was used to detect the primary antibody.")
Influenza A Virus H1N1 Neuraminidase (NA) antibody [GT288] detects Influenza A Virus H1N1 Neuraminidase (NA) protein by western blot analysis. A. 30 μg DF1 whole cell lysate/extract (untreated) B. 30 μg whole cell lysate/extract of Influenza A (WSN) infected DF1 cell for 10 hr 10% SDS-PAGE Influenza A Virus H1N1 Neuraminidase (NA) antibody [GT288] (GTX629696) dilution: 1:1000 The HRP-conjugated anti-mouse IgG antibody (GTX213111-01) was used to detect the primary antibody.
Influenza A virus H1N1 NA (Neuraminidase) antibody [GT288]
GTX629696
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameInfluenza A virus H1N1 NA (Neuraminidase) antibody [GT288]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDGT288
- Concentration1 mg/ml
- ConjugateUnconjugated
- HostMouse
- IsotypeIgG2a
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Wang G, Zhao Y, Zhou Y, et al. PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence. PLoS Pathog. 2022,18(4):e1010446. doi: 10.1371/journal.ppat.1010446Read this paper
- Liu X, Xu F, Ren L, et al. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes. Nat Commun. 2021,12(1):4427. doi: 10.1038/s41467-021-24724-2Read this paper
- Lai Y, Han T, Zhan S, et al. Antiviral Activity of Isoimperatorin Against Influenza A Virus in vitro and its Inhibition of Neuraminidase. Front Pharmacol. 2021,12:657826. doi: 10.3389/fphar.2021.657826Read this paper
- Slaine PD, Kleer M, Duguay BA, et al. Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation. J Virol. 2021,95(11):pii: JVI.00453-21. doi: 10.1128/JVI.00453-21.Read this paper
- Ha TKQ, Lee BW, Nguyen NH, et al. Antiviral Activities of Compounds Isolated from Pinus densiflora (Pine Tree) against the Influenza A Virus. Biomolecules. 2020,10(5). doi: 10.3390/biom10050711Read this paper
- Groenke N, Trimpert J, Merz S, et al. Mechanism of Virus Attenuation by Codon Pair Deoptimization. Cell Rep. 2020,31(4):107586. doi: 10.1016/j.celrep.2020.107586Read this paper
- Omi J, Watanabe-Takahashi M, Igai K, et al. The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection. Nat Commun. 2020,11(1):162. doi: 10.1038/s41467-019-13974-wRead this paper
- Zhang X, Xia Y, Yang L, et al. Brevilin A, a Sesquiterpene Lactone, Inhibits the Replication of Influenza A Virus In Vitro and In Vivo. Viruses. 2019,11(9). doi: 10.3390/v11090835Read this paper
- Hong JY, Chen TH, Chen YJ, et al. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development. Antiviral Res. 2019,164:12-22. doi: 10.1016/j.antiviral.2019.02.004Read this paper
- Guo H, Rabouw H, Slomp A, et al. Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces. PLoS Pathog. 2018,14(8):e1007233. doi: 10.1371/journal.ppat.1007233Read this paper